Letters
T
he confirmation of Omicron Variant of Concern today by India, the first two cases in WHO South-East Asia Region, was not unexpected in view of the interconnected world that we live in. This emphasises on the need for all countries to step up surveillance, to be on alert and rapidly detect any importation and take measures to curtail further spread of the virus. The response measures for all variants, including Omicron, is the same as that for SARs CoV2.
Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia Region
At Neuberg, our strategic decisions are governed by our commitment to making state-of-the-art technology and new generation diagnostics accessible and affordable to all sections of the society. With our most recent expansion, we are one step closer to achieving our mission of universal access. Dr GSK Velu, Chairman and Managing Director, Neuberg Diagnostics The Case Against IMA book is a befitting response to the police complaint filed by Indian Medical Association (IMA) against me for carrying out naturopathy based non- invasive treatments of ailments. I have posed many challenges to the IMA through the book. IMA should work as an organisation to serve the people and not to serve the parochial interests of pharmaceutical companies, and gangs of doctors. Dr Biswaroop Roy Chowdhury, internationally-acclaimed Medical Nutritionist
India has done a fabulous job in reaching the right people with HIV services over the last many decades and as a result, 76 per cent of the PLHIV are aware of their status due to rigorous testing strategies (Sankalak 2020). We have many traditional ways of testing for HIV. One can go to a facility called Integrated Counselling and Testing Center to get tested, counselled, and linked for further follow ups. However, due to systemic barriers, uptake of traditional testing gets impacted by the distance that one must travel to the facility, the money that one must spend and lose because of time devoted to testing and most importantly, the fear of losing confidentiality and stigma of going to designated HIV testing facilities. Dr Jalpa Thakker, Director - Programs, Accelerate, Johns Hopkins University School of Medicine
FOLLOW US ON... @indiamedtoday facebook.com/indiamedtoday PLS ADDRESS YOUR LETTERS TO: The Editor, IndiaMedToday and mail to editorial@indiamedtoday.com Pls indicate clearly if you want to publish your views/opinions for this page.
6
December 2021
